|
News Release |
1001
Connecticut Ave, NW - Ste 710 - Washington, DC 20036 |
June 21, 2001
California County
Receives Government Pot for Medical Research
Municipality Will Be Nation's Only Legal State Distributor of
Medical Marijuana
San Mateo,
CA: San Mateo County health officials received their first shipment of
government grown medical marijuana last week. The federally-provided pot
will be dispensed imminently to local AIDS patients as part of a groundbreaking
local study to better determine the herb's therapeutic value. San Mateo
County is the only municipality in the country allowed to legally distribute
medicinal marijuana.
"I see this as a milestone - a first
step - toward the day when this drug will be available for doctors to prescribe
for people who are suffering in great pain," said Michael Nevin, President of
the San Mateo County Board of Supervisors. Nevin first began lobbying for
the program in 1997 and received federal permission to implement the plan last
November.
In April, local health officials
requested 300 marijuana cigarettes from the federal National Institute on Drug
Abuse (NIDA). The shipment - approximately a two-month supply, according
to health officials - arrived at San Francisco International Airport last
Wednesday. Federal researchers cultivate marijuana for research purposes
at the University of Mississippi at Oxford. NIDA is the only legal
supplier of marijuana in the United States.
ixty local AIDS patients will have
access to the government-grown pot as part of an 18-month study to evaluate the
drug's ability to mitigate symptoms of the AIDS wasting syndrome. Only
patients who have prior experience using marijuana are eligible to participate
in the program, which will be led by Dr. Dennis Israelski, chief of infectious
diseases and AIDS medicine at San Mateo County Hospital and Clinics.
Although there exists a large body of
anecdotal evidence indicating that marijuana provides symptomatic relief for
patients with AIDS, almost no scientific research has been conducted on humans.
Preliminary results announced last year from an ongoing University of
California-San Francisco study found that patients who smoked marijuana gained
significantly more weight on average than those receiving a placebo, and had
slightly lower viral levels.
Patients interested in participating
in the trial may contact Mark Traves, Project Coordinator, at (650) 573-2748.
For more information, please
contact either Allen St. Pierre or Paul Armentano of The NORML Foundation at
(202) 483-8751.
Scotland Yard To Stop Citing Marijuana Smokers
London,
United Kingdom: London police officers will no longer arrest or
caution marijuana smokers in the southern part of the city, officials announced
Friday. Instead, police will issue verbal warnings to users and confiscate
their pot, under a pilot program backed by Scotland Yard, Britain's largest
police force.
If the program proves successful,
police will expand the policy city-wide, a Scotland yard spokeswoman told
Reuters News Service.
Police officials argue that the
policy will free officers to focus on more serious crimes. Last year a
report by the British Police Foundation - an independent criminal justice
research organization - endorsed decriminalizing marijuana.
A national poll commissioned by the
Guardian newspaper last year found that eight out of ten Britons favored
decriminalizing marijuana. Two-thirds of respondents said that smoking pot
was no more dangerous than smoking cigarettes or drinking alcohol.
For more information, please
contact Allen St. Pierre, NORML Foundation Executive Director, at (202)
483-8751.
AMA Rejects Institute of Medicine, Others Support for"Compassionate Access" to Medical Marijuana
Chicago, IL:
The American Medical Association's (AMA) House of Delegates rejected a proposal
this week to support the limited use of medical marijuana.
The proposal, put forth by the
organization's Council on Scientific Affairs, asked Delegates to "affirm the
appropriateness of [the] 'compassionate use' of marijuana and related
cannabinoids in carefully controlled programs." Instead, the AMA endorsed
"the free and unfettered exchange of information on treatment alternatives."
The AMA's failure to approve the
"compassionate use" of marijuana places the organization squarely at odds with
one of the chief recommendations of the National Academy of Sciences Institute
of Medicine (IOM). In 1999, the IOM backed the medical use of marijuana in
single patient trials, stating that there exists no other "alternative for
people suffering from chronic conditions that might be relieved by smoking
marijuana."
The AMA's rejection also runs
contrary to views held by the American Public Health Association, AIDS Action
Council and the American Preventive Health Association, all of which support
"compassionate access" to medical marijuana under limited circumstances.
"The AMA seems more concerned about
pleasing the government than about helping seriously ill patients," NORML
Executive Director R. Keith Stroup said. "Their failure to speak out in
favor of the medicinal use of marijuana is a shameful act of cowardice."
Presently, the Canadian government
grants federal exemptions to seriously ill patients who use marijuana
medicinally. The U.S. initiated a similar "compassionate access" program
in 1978, but eventually closed the program in 1992 to new applicants.
For more information, please
contact either Allen St. Pierre or Paul Armentano of The NORML Foundation at
(202) 483-8751.
- End -